Cargando…

Long-Term Antibody Response against SARS-CoV-2 in Health Care Workers: Effectiveness of Homologous and Heterologous Regimens and Their Relation to Systemic Vaccine-Associated Symptoms

This prospective study provides data on the long-term humoral immunogenicity of a heterologous off-label vaccine regimen combining the adenoviral-vectored ChAdOx1 nCoV-19 from Astra-Zeneca (ChAd) with the mRNA-1273 vaccine from Moderna (m1273) in comparison with two different homologous mRNA vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kierkegaard, Helene, Røge, Birgit Thorup, Nissen, Amanda, Madsen, Jonna Skov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611514/ https://www.ncbi.nlm.nih.gov/pubmed/36298464 http://dx.doi.org/10.3390/vaccines10101599

Ejemplares similares

SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
por: von Huth, Sebastian, et al.
Publicado: (2021)

Anti‐SARS‐CoV‐2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID‐19 vaccination regimens
por: Kittikraisak, Wanitchaya, et al.
Publicado: (2022)

Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants
por: Buathong, Rome, et al.
Publicado: (2022)

Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2023)

Antibody Response to COVID-19 Vaccines in Healthcare Workers: Which One is More Successful? Homologous or Heterologous?
por: Karakoc, Zehra Cagla, et al.
Publicado: (2023)

THE USE OF HOMOLOGOUS AND HETEROLOGOUS ROTAVIRUS ANTIBODIES FOR THE PREVENTION OF ROTAVIRUS GASTROENTERITIS
por: Losonsky, Genevieve A, et al.
Publicado: (1984)

Antibody response after two doses of homologous or heterologous SARS‐CoV‐2 vaccines in healthcare workers at health promotion centers: A prospective observational study
por: Nah, Eun‐Hee, et al.
Publicado: (2022)

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
por: Bekliz, Meriem, et al.
Publicado: (2022)

Evaluation of Transplacental Antibody Transfer in Pregnant Women Immunized with Different SARS-CoV-2 Homologous or Heterologous Schemes
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2023)

Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations
por: Mulleners, Sien J., et al.
Publicado: (2023)

The efficacy of the prime-boost regimen for heterologous infectious bronchitis vaccines mandates the administration of homologous vaccines
por: Al-Kubati, Anwar A. G., et al.
Publicado: (2022)

Warming Prior to Heel Stick: Blood Sample Quality and Infant Comfort—A Randomized Controlled Trial
por: Toennesen, Ulla List, et al.
Publicado: (2023)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
por: Au, Wing Ying, et al.
Publicado: (2022)

Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
por: Gaete-Argel, Aracelly, et al.
Publicado: (2023)

Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology
por: Olsen, Dorte Aa., et al.
Publicado: (2021)

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
por: Körber, Nina, et al.
Publicado: (2023)

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
por: Gareayaghi, Nesrin, et al.
Publicado: (2022)

Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice
por: Zhao, Wei, et al.
Publicado: (2021)

Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
por: Zhang, Xiaoyin, et al.
Publicado: (2023)

A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
por: Baek, Yae Jee, et al.
Publicado: (2023)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
por: Honfi, Dániel, et al.
Publicado: (2022)

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
por: Markewitz, Robert Daniel Heinrich, et al.
Publicado: (2022)

A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
por: Mordmüller, Benjamin, et al.
Publicado: (2022)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
por: Orlandi, Chiara, et al.
Publicado: (2023)

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
por: Roth, Nicole, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
por: Heinen, Natalie, et al.
Publicado: (2022)

ACTION ON FIBROBLASTS OF EXTRACTS OF HOMOLOGOUS AND HETEROLOGOUS TISSUES
por: Carrel, Alexis, et al.
Publicado: (1923)

μ-Opioid receptor desensitization: homologous or heterologous?
por: Llorente, Javier, et al.
Publicado: (2012)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_flm448mvrmrnp1lik272mrb6il